Efficacy and Safety of Medical Treatment in Acute Angle Closure Glaucoma at Thammasat Hospital


  • Sutee Ananprasert Department of Ophthalmology, Thammasat University Hospital
  • Chayanee Penpian Department of Ophthalmology, Thammasat University Hospital


Acute angle closure glaucoma, Medication treatment, Medication


Introduction: Acute angle closure glaucoma (AACG) is a suddenly high intraocular pressure (IOP) from pupillary block which cause optic neuropathy. The key concept of AACG management is to break pupillary block and lower the IOP in order to prevent blindness. The IOP-lowering medical treatments are prescribed to reduce the IOP in the initial stage, which are used to help clear up the cornea and reduce ocular inflammation before performing laser-peripheral iridotomy (L-PI). The purpose of this study is to determine the effectiveness and safety of medical treatments in the initial management of AACG at Thammasat University Hospital.

Methods: Prospective pre-experimental study. Twelve cases of AACG were diagnosed at Thammasat Hospital. All participants were enrolled in this study. Patients without a history of drug allergy underwent a protocol of management in which they received one tablet of oral acetazolamide (250 mg), followed by one tablet every six hours, topical timolol (0.5%) twice daily and brimonidine (0.2%) twice daily which is applied to the affected eye. Patients were recorded IOP at regular interval, and patients were given medication until resolution of AACG which is defined as IOP <= 30 mmHg and resolution of acute symptoms. Qualitative data were calculated into percentage. Quantitative data were calculated as mean and standard deviation.

Results: Fifteen eyes of 12 patients, 5 (41.67%) men and 7 (58.33%) women, with the mean age of 70.58 (6.1) years were studied. With medical therapy, the number of AACG resolved within 1, 12, and 24 hours are 6 (50%), 4 (33.33%), and 1 (8.33%), respectively. No serious adverse effects of IOP-lowering medical treatment were observed in this study. Successful L-PI was performed in all subjects within 1 to 3.5 days after the medical treatments were applied.

Conclusion: According to the result in this study found that IOP-lowering medical treatments prescribed to reduce initial stage of IOP is effective and safe. Medical management of AACG should still remain as the first-line treatment.


Download data is not yet available.


Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081-2090.

Foster PJ, Oen FT, Machin D, Ng TP, Devereux JG, Johnson GJ, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol. 2000;118(8):1105-1111.

Tso MO, Naumann GO, Zhang SY. Studies of prevalence of blindness in the Asia-Pacific region and the worldwide initiative in ophthalmic education. Am J Ophthalmol. 1998;126(4):582-585.

Bourne RR, Sukudom P, Foster PJ, Tantisevi V, Jitapunkul S, Lee PS, et al. Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok. Br J Ophthalmol. 2003;87(9):1069-1074.

Foster PJ, Machin D, Wong TY, Ng TP, Kirwan JF, Johnson GJ, et al. Determinants of intraocular pressure and its association with glaucomatous optic neuropathy in Chinese Singaporeans: the Tanjong Pajar Study. Invest Ophthalmol Vis Sci. 2003;44(9):2885-3891.

Brody S, Erb C, Veit R, et al. Intraocular pressure change: the influence of psychological stress and the Valsava maneuver. Biol Psychol. 1999;51:43-57.

Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48-56.

Vijaya L, George R, Asokan R, Velumuri L, Ramesh SV. Prevalence and causes of low vision and blindness in an urban population: The Chennai Glaucoma Study. Indian J Ophthalmol. 2014;62(4):477-81.

R Rand Allingham, Karim Damji, Sharon Freedman, Sayoko Moroi, George Shafranov. Shields’ textbook of glaucoma. Fifth edition. LWW. 2004.

Ramli N, Chai SM, Tan GS, Husain R, Hoh ST, Ho CL, Aung T. Efficacy of medical therapy in the initial management of acute primary angle closure in Asians. Eye (Lond). 2010;24(10):1599-602.

Chan PP, Pang JC, Tham CC. Acute primary angle closure-treatment strategies, evidences and economical considurations. Eye. 2019;33:110-119.

Huang W, Chen S, Gao X, Yang M, Zhang J, Li X, Wang W, Zhou M, Zhang X, Zhang X. Inflammation-related cytokines of aqueous humor in acute primary angle-closure eyes. Invest Ophthalmol Vis Sci. 2014 Feb 24;55(2):1088-94.




How to Cite

Ananprasert, S. and Penpian, C. 2023. Efficacy and Safety of Medical Treatment in Acute Angle Closure Glaucoma at Thammasat Hospital. Asian Medical Journal and Alternative Medicine. 23, 3 (Dec. 2023), 39–43.



Original Articles